Trademark: 79350987
Status Date
Tuesday, February 20, 2024
Filing Date
Thursday, April 7, 2022
Published for Opposition
Tuesday, February 20, 2024
9 Scientific research and laboratory apparatus for drug screening or potency assays; cell culture apparatus for laboratory use, in particular cell culture plates and tissue culture plates for the generation and/or cultivation of engineered tissue
5 Pharmaceutical and veterinary preparations, in particular cells and tissues for treatment of cardiac diseases, degenerative muscular diseases, fibrotic diseases, neurodegenerative diseases, connective tissue diseases or disorders with impaired scaring and wound healing; pharmaceutical preparations for the renewal and regeneration of organs; pharmaceutical preparations for use in cellular therapy; biological tissue derived from stem cells for medical purposes; tissue-regenerative pharmaceutical preparations
1 Chemicals for use in industry and science, in particular reagents for cultivation of cells and tissue; cells for research or for scientific purposes, namely, cells, in particular genetically modified cells, human cells and cells derived from induced pluripotent stem cells, in particular cardiomyocytes derived from human induced pluripotent stem cells, skeletal cells derived from human induced pluripotent stem cells, stroma cells derived from human induced pluripotent stem cells, and neuronal cells derived from human induced pluripotent stem cells; biological tissues, other than for medical or veterinary purposes, namely, tissues in particular engineered tissues, in particular tissue comprising cells derived from induced pluripotent stem cells and macroscale muscle tissue, in particular human heart muscle constructed from cardiomyocytes derived from human induced pluripotent stem cells, human skeletal muscle constructed from skeletal cells derived from human induced pluripotent stem cells, human fibrotic tissue constructed from stroma cells derived from human induced pluripotent stem cells, connective tissue constructed from connective tissue cells derived from human induced pluripotent stem cells, brain tissue derived from human induced pluripotent stem cells, and neuronal organoids; biological preparation for use in cell cultures other than for medical or veterinary use; biological tissue cultures, other than for medical or veterinary purposes; biological tissue cultures, other than for medical or veterinary purposes, namely, disease models based on engineered tissue or engineered cells
42 Scientific and industrial research in particular in the biochemical, diagnostic or pharmaceutical fields; biochemical or pharmaceutical laboratory services, in particular in the field of cultivation of cells and tissues; drug discovery services, in particular drug discovery services based on tissue engineered organ platforms; scientific and technological services and research in the field of regenerative medicine; cell culture services for scientific and research purposes, for others
Mar 25, 2024
Notification Of Possible Opposition - Processed By Ib
Mar 6, 2024
Notification Of Possible Opposition Sent To Ib
Mar 6, 2024
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 26, 2024
Notification Processed By Ib
Feb 20, 2024
Published For Opposition
Feb 7, 2024
Notification Of Possible Opposition Sent To Ib
Feb 7, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 1, 2024
Notification Of Notice Of Publication E-Mailed
Feb 1, 2024
Notification Of Notice Of Publication E-Mailed
Jan 31, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 18, 2024
Approved For Pub - Principal Register
Sep 11, 2023
Teas/Email Correspondence Entered
Sep 11, 2023
Correspondence Received In Law Office
Sep 11, 2023
Teas Response To Office Action Received
Apr 25, 2023
Refusal Processed By Ib
Mar 31, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Mar 31, 2023
Refusal Processed By Mpu
Feb 12, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Feb 11, 2023
Non-Final Action Written
Jan 25, 2023
Assigned To Examiner
Oct 4, 2022
Application Filing Receipt Mailed
Sep 30, 2022
New Application Office Supplied Data Entered
Sep 29, 2022
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
